Jun 17, 2022
7:5
For every 5 shares held, investors received 7. The price per share adjusted from $42.67 to $30.48.
The split itself did not change the total investment value.
Zhejiang Starry Pharmaceutical Co., Ltd. Class A (SSE:603520) operates in the Medical specialties industry.
Zhejiang Starry Pharmaceutical Co., Ltd. Class A company overviewZhejiang Starry Pharmaceutical Co., Ltd. Class A's most recent stock split was on June 17, 2022. It was a 7-for-5 forward split, so shareholders received 7 shares for every 5 they held.
Zhejiang Starry Pharmaceutical Co., Ltd. Class A (SSE:603520) has split its stock 3 times: a 7-for-5 split on June 25, 2019, a 7-for-5 split on June 1, 2020, and a 7-for-5 split on June 17, 2022.
Zhejiang Starry Pharmaceutical Co., Ltd. Class A has split its stock 3 times. This history records 3 forward splits between June 25, 2019 and June 17, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Zhejiang Starry Pharmaceutical Co., Ltd. Class A's 7-for-5 split on June 17, 2022, every 5 shares became 7 shares.
Zhejiang Starry Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on June 17, 2022, 4 years ago. Companies announce splits in advance, and any new SSE:603520 split will appear on this page.
Already premium?